Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature
Abstract
:Author Contributions
Funding
Informed Consent Statement
Conflicts of Interest
References
- Ducimetiere, F.; Lurkin, A.; Ranchere-Vince, D.; Decouvelaere, A.V.; Peoc’h, M.; Istier, L.; Chalabreysse, P.; Muller, C.; Alberti, L.; Bringuier, P.P.; et al. Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing. PLoS ONE 2011, 6, e20294. [Google Scholar] [CrossRef] [PubMed]
- Sbaraglia, M.; Bellan, E.; Dei Tos, A.P. The 2020 WHO Classification of Soft Tissue Tumours: News and perspectives. Pathologica 2021, 113, 70–84. [Google Scholar] [CrossRef] [PubMed]
- Crago, A.M.; Dickson, M.A. Liposarcoma: Multimodality Management and Future Targeted Therapies. Surg. Oncol. Clin. N. Am. 2016, 25, 761–773. [Google Scholar] [CrossRef] [PubMed]
- Damerell, V.; Pepper, M.S.; Prince, S. Molecular mechanisms underpinning sarcomas and implications for current and future therapy. Signal Transduct. Target. Ther. 2021, 6, 246. [Google Scholar] [CrossRef]
- Mertens, F.; Antonescu, C.R.; Mitelman, F. Gene fusions in soft tissue tumors: Recurrent and overlapping pathogenetic themes. Genes Chromosomes Cancer 2016, 55, 291–310. [Google Scholar] [CrossRef] [PubMed]
- Mandahl, N.; Bartuma, H.; Magnusson, L.; Isaksson, M.; Macchia, G.; Mertens, F. HMGA2 and MDM2 expression in lipomatous tumors with partial, low-level amplification of sequences from the long arm of chromosome 12. Cancer Genet. 2011, 204, 550–556. [Google Scholar] [CrossRef] [PubMed]
- Serrati, S.; De Summa, S.; Pilato, B.; Petriella, D.; Lacalamita, R.; Tommasi, S.; Pinto, R. Next-generation sequencing: Advances and applications in cancer diagnosis. Onco Targets Ther. 2016, 9, 7355–7365. [Google Scholar] [CrossRef]
- Tirro, E.; Martorana, F.; Micale, G.; Inzerilli, N.; Carciotto, R.; Romano, C.; Longhitano, C.; Motta, G.; Lanzafame, K.; Stella, S.; et al. Next generation sequencing in a cohort of patients with rare sarcoma histotypes: A single institution experience. Pathol. Res. Pract. 2022, 232, 153820. [Google Scholar] [CrossRef]
- Crago, A.M.; Brennan, M.F. Principles in Management of Soft Tissue Sarcoma. Adv. Surg. 2015, 49, 107–122. [Google Scholar] [CrossRef]
- Montgomery, E.; Fisher, C. Paratesticular liposarcoma: A clinicopathologic study. Am. J. Surg. Pathol. 2003, 27, 40–47. [Google Scholar] [CrossRef]
- Li, Z.; Zhao, L.; Chen, P.; Liu, Y.; Ding, Y.; Sun, S.; Yang, S.; Lai, Y. Giant paratesticular liposarcoma: A case report and review of the literature. Mol. Clin. Oncol. 2018, 8, 613–616. [Google Scholar] [CrossRef] [PubMed]
- Sopena-Sutil, R.; Silan, F.; Butron-Vila, M.T.; Guerrero-Ramos, F.; Lagaron-Comba, E.; Passas-Martinez, J. Multidisciplinary approach to giant paratesticular liposarcoma. Can. Urol. Assoc. J. 2016, 10, E316–E319. [Google Scholar] [CrossRef] [PubMed]
- Chiodini, S.; Luciani, L.G.; Cai, T.; Molinari, A.; Morelli, L.; Cantaloni, C.; Barbareschi, M.; Malossini, G. Unusual case of locally advanced and metastatic paratesticular liposarcoma: A case report and review of the literature. Arch. Ital. Urol. Androl. 2015, 87, 87–89. [Google Scholar] [CrossRef] [PubMed]
- Alyousef, H.; Osman, E.M.; Gomha, M.A. Paratesticular liposarcoma: A case report and review of the literature. Case Rep. Urol. 2013, 2013, 806289. [Google Scholar] [CrossRef] [PubMed]
- Grossi, U.; Crucitti, A.; Pierconti, F. Giant spermatic cord liposarcoma. Int. Surg. 2014, 99, 407–409. [Google Scholar] [CrossRef]
- Mouden, K.; Wakrim, S.; Semmar, A. Paratesticular liposarcoma: A case report. Pan Afr. Med. J. 2019, 33, 282. [Google Scholar] [CrossRef]
- Coleman, J.; Brennan, M.F.; Alektiar, K.; Russo, P. Adult spermatic cord sarcomas: Management and results. Ann. Surg. Oncol. 2003, 10, 669–675. [Google Scholar] [CrossRef]
- Vitale, S.R.; Martorana, F.; Stella, S.; Motta, G.; Inzerilli, N.; Massimino, M.; Tirro, E.; Manzella, L.; Vigneri, P. PI3K inhibition in breast cancer: Identifying and overcoming different flavors of resistance. Crit. Rev. Oncol. Hematol. 2021, 162, 103334. [Google Scholar] [CrossRef]
- Lee, A.T.J.; Thway, K.; Huang, P.H.; Jones, R.L. Clinical and Molecular Spectrum of Liposarcoma. J. Clin. Oncol. 2018, 36, 151–159. [Google Scholar] [CrossRef]
- Kalyvas, K.D.; Kotakidou, R.; Trantos, A.; Yannakoyorgos, K.; Hatzichristou, D.G. Paratesticular well-differentiated, adipocytic type liposarcoma presenting as inguinal hernia. Urol. Int. 2004, 72, 264–268. [Google Scholar] [CrossRef]
- Omidvari, S.; Hamedi, S.H.; Moaddab-Shoar, L.; Nasrollahi, H.; Daneshbod, Y.; Mosleh-Shirazi, M.A.; Ansrai, M.; Mohammadianpanah, M.; Ahmadloo, N.; Mosalaei, A. Paratesticular liposarcoma; a case report. Iran J. Cancer Prev. 2014, 7, 239–243. [Google Scholar] [PubMed]
- Li, F.; Tian, R.; Yin, C.; Dai, X.; Wang, H.; Xu, N.; Guo, K. Liposarcoma of the spermatic cord mimicking a left inguinal hernia: A case report and literature review. World J. Surg. Oncol. 2013, 11, 18. [Google Scholar] [CrossRef] [PubMed]
- Keenan, R.A.; Nic An Riogh, A.U.; Stroiescu, A.; Fuentes, A.; Heneghan, J.; Cullen, I.M.; Daly, P.J. Paratesticular sarcomas: A case series and literature review. Ther. Adv. Urol. 2019, 11, 1756287218818029. [Google Scholar] [CrossRef] [PubMed]
- Shim, E.J.; Yoon, M.A.; Yoo, H.J.; Chee, C.G.; Lee, M.H.; Lee, S.H.; Chung, H.W.; Shin, M.J. An MRI-based decision tree to distinguish lipomas and lipoma variants from well-differentiated liposarcoma of the extremity and superficial trunk: Classification and regression tree (CART) analysis. Eur. J. Radiol. 2020, 127, 109012. [Google Scholar] [CrossRef]
- Thway, K.; Flora, R.; Shah, C.; Olmos, D.; Fisher, C. Diagnostic utility of p16, CDK4, and MDM2 as an immunohistochemical panel in distinguishing well-differentiated and dedifferentiated liposarcomas from other adipocytic tumors. Am. J. Surg. Pathol. 2012, 36, 462–469. [Google Scholar] [CrossRef]
- Clay, M.R.; Martinez, A.P.; Weiss, S.W.; Edgar, M.A. MDM2 Amplification in Problematic Lipomatous Tumors: Analysis of FISH Testing Criteria. Am. J. Surg. Pathol. 2015, 39, 1433–1439. [Google Scholar] [CrossRef]
- Radaelli, S.; Desai, A.; Hodson, J.; Colombo, C.; Roberts, K.; Gourevitch, D.; Gronchi, A. Prognostic factors and outcome of spermatic cord sarcoma. Ann. Surg. Oncol. 2014, 21, 3557–3563. [Google Scholar] [CrossRef]
- Ayari, Y.; Sellami, A.; Boussaffa, H.; Zehani, A.; Ben Rhouma, S.; Nouira, Y. About a case of paratesticular myxoid liposarcoma. Urol. Case Rep. 2018, 21, 27–28. [Google Scholar] [CrossRef]
- Khandekar, M.J.; Raut, C.P.; Hornick, J.L.; Wang, Q.; Alexander, B.M.; Baldini, E.H. Paratesticular liposarcoma: Unusual patterns of recurrence and importance of margins. Ann. Surg. Oncol. 2013, 20, 2148–2155. [Google Scholar] [CrossRef]
- Jones, R.L.; Fisher, C.; Al-Muderis, O.; Judson, I.R. Differential sensitivity of liposarcoma subtypes to chemotherapy. Eur. J. Cancer 2005, 41, 2853–2860. [Google Scholar] [CrossRef]
- Demicco, E.G.; Griffin, A.M.; Gladdy, R.A.; Dickson, B.C.; Ferguson, P.C.; Swallow, C.J.; Wunder, J.S.; Wang, W.L. Comparison of published risk models for prediction of outcome in patients with extrameningeal solitary fibrous tumour. Histopathology 2019, 75, 723–737. [Google Scholar] [CrossRef] [PubMed]
- Boltze, C.; Schneider-Stock, R.; Jager, V.; Roessner, A. Distinction between lipoma and liposarcoma by MDM2 alterations: A case report of simultaneously occurring tumors and review of the literature. Pathol. Res. Pract. 2001, 197, 563–568. [Google Scholar] [CrossRef] [PubMed]
- Unachukwu, U.; Chada, K.; D’Armiento, J. High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia. Int. J. Mol. Sci. 2020, 21, 3151. [Google Scholar] [CrossRef]
- Assi, T.; Kattan, J.; Rassy, E.; Nassereddine, H.; Farhat, F.; Honore, C.; Le Cesne, A.; Adam, J.; Mir, O. Targeting CDK4 (cyclin-dependent kinase) amplification in liposarcoma: A comprehensive review. Crit. Rev. Oncol. Hematol. 2020, 153, 103029. [Google Scholar] [CrossRef] [PubMed]
- Movva, S.; Mehren, M.V.; Handorf, E.A.; Morgan, J.A.; Nathenson, M.; Thornton, K.A.; Tetzlaff, E.D.; Barker, E.; Thibodeau, L.; Harley, A.C.; et al. SAR-096: A phase II trial of ribociclib in combination with everolimus in advanced dedifferentiated liposarcoma (DDL), and leiomyosarcoma (LMS). J. Clin. Oncol. 2020, 38, 11544. [Google Scholar] [CrossRef]
- Wang, X.Q.; Wang, X.Q.; Hsu, A.; Goytain, A.; Ng, T.L.T.; Nielsen, T.O. A Rapid and Cost-Effective Gene Expression Assay for the Diagnosis of Well-Differentiated and Dedifferentiated Liposarcomas. J. Mol. Diagn. 2021, 23, 274–284. [Google Scholar] [CrossRef]
- The Cancer Genome Atlas Research Network. Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas. Cell 2017, 171, 950–965.e928. [Google Scholar] [CrossRef] [Green Version]
Author | Type | Age | Growth Time | Size (cm) | Side | Pain | Initial Diagnosis | Primary Surgery | Margins | CT Scan | Post-Surgical Treatment(s) |
---|---|---|---|---|---|---|---|---|---|---|---|
Zuwei (2018) [11] | DDL | 51 | 2 m | 8 | Right | No | Spermatocytoma | Orchiectomy | R0 | NA | None |
Sopena-Sutil (2016) [12] | WDL | 56 | 25 y | 40 × 40 | Left | No | Liposarcoma | Orchiectomy and spermatic cord ligation | R0 | Negative | None |
Alyousef (2013) [14] | WDL | 75 | 6 y | 8.5 × 5.4 | Right | No | Suspicious scrotal mass | Orchiectomy and inguinal canal contents resection | R0 | Negative | None |
Grossi (2014) [15] | WDL/MRCL | 81 | 4 y | 28 × 30 | Right | No | Suspicious scrotal mass | Orchiectomy and high spermatic cord ligation | NA | Negative | None |
Kalyvas (2004) [20] | WDL | 72 | 5 y | 10 × 9 | Left | No | Inguinal hernia | Orchiectomy and spermatic cord ligation | NA | Negative | None |
Omidvari (2014) [21] | WDL | 55 | 30 y | NA | Left | No | Scrotal lipoma | Tumor resection | R1 | Negative | Re-surgery and RT |
Li (2013) [22] | WDL/MRCL | 53 | 2 y | 5.5 × 4.2 | Left | No | Inguinal hernia | Orchiectomy, spermatic cord ligation and inguinal lymph node biopsy | R0 | Negative | None |
Keenan (2019) [23] | DDL | 82 | 1.5 m | 11 × 9 | Left | Yes | Scrotal hematoma | Hemiscrotectomy | R1 | Positive (Pelvis) | Palliative RT |
Keenan (2019) [23] | WDL | 54 | 24 y | 3 × 3 | Left | Yes | Inguinal hernia | Tumor resection | NA | Positive (Lung) | NA |
Ayari (2018) [28] | MRCL | 67 | 8 m | 4 | Right | No | Suspicious scrotal mass | Orchiectomy and high spermatic cord ligation | NA | Negative | None |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Pavone, G.; Romano, C.; Martorana, F.; Motta, L.; Salvatorelli, L.; Zanghì, A.M.; Magro, G.; Vigneri, P. Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature. Diagnostics 2022, 12, 2160. https://doi.org/10.3390/diagnostics12092160
Pavone G, Romano C, Martorana F, Motta L, Salvatorelli L, Zanghì AM, Magro G, Vigneri P. Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature. Diagnostics. 2022; 12(9):2160. https://doi.org/10.3390/diagnostics12092160
Chicago/Turabian StylePavone, Giuliana, Chiara Romano, Federica Martorana, Lucia Motta, Lucia Salvatorelli, Antonio Maria Zanghì, Gaetano Magro, and Paolo Vigneri. 2022. "Giant Paratesticular Liposarcoma: Molecular Characterization and Management Principles with a Review of the Literature" Diagnostics 12, no. 9: 2160. https://doi.org/10.3390/diagnostics12092160